DJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 26-Sep-2023 / 12:59 GMT/BST=----------------------------------------------------------------------------------------------------------------------
The Vanguard Group, Inc. Form 8.3 26-Sep-2023 / 12:59 GMT/BST =---------------------------------------------------------------------------------------------------------------------- Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION a. Full name of discloser The Vanguard Group, Inc. b.
Class of relevant security USUSD0.0001 ordinary shares Interests Short positions Number % Number % 1. Relevant securities owned and/or controlled 21,570,652 9.42% 2. Cash-settled derivatives 3. Stock-settled derivatives and agreements to purchase/ sell Total 21,570,652 9.42% All interests and all short positions should be disclosed.
Class of Product Exercising/ Exercise relevant description exercised Number of price per security e.g. call against securities unit option Other dealings 4.
Is a Supplemental Form 8 attached? No Date of disclosure 26 September 2023 Contact name Shawn Acker Telephone number 001-610-669-6713 Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
- The Vanguard Group, Inc.: Dechra Pharmaceuticals plcDJ Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 26-Sep-2023 / 12:58 GMT/BST=----------------------------------------------------------------------------------------------------------------------
Read more »
MDAX-Papier KION GROUP-Aktie: So viel hätten Anleger an einem frühen KION GROUP-Investment verlorenBei einem frühen KION GROUP-Investment müssten Anleger so viel Verlust verbuchen.
Read more »